Clinical trials [1] have shown unprecedented reductions in HbA1c (1.242.58%) and body weight (5.411.7 kg), outperforming selective GLP-1 agonists and basal insulin to support improved glycemic control and meaningful weight loss
Non-arteritic anterior ischemic optic neuropathy (NAION) is when blood and oxygen flow to the optic nerve is compromised, causing optic nerve swelling and sudden blindness in one eye, typically without any pain
Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) Expanded Indication Plus paclitaxel, with or without bevacizumab, for the treatment of adults with PD-L1+ (Combined Positive Score [CPS] 1), as determined by an FDA-authorized test, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal carcinoma, who have received one or two prior systemic treatment regimens
to ask is , I'm on mj, is this mood improvement a primary or secondary effect My gut feeling is that its a direct effect and not secondary due to just wt loss
Both were placed on FDA Category 2 in September 2023, removed in September 2024 after withdrawn nominations, and reviewed by PCAC in late 2024 with FDA recommending against 503A Bulks inclusion
